buprenorphine and naloxone
buprenorphine and naloxone is listed in the FDA National Drug Code directory with 15 NDC codes, marketed under brand names including Buprenorphine and Naloxone, buprenorphine and naloxone. Available dosage forms: film, tablet, film, soluble.
Drug Details
- Generic Name
- buprenorphine and naloxone
- Brand Names
- Buprenorphine and Naloxone, buprenorphine and naloxone
- Application Number
- ANDA212756
- Sponsor
- Aveva Drug Delivery Systems Inc.
- NDC Codes
- 15
- Dosage Forms
- FILM, TABLET, FILM, SOLUBLE
- Routes
- BUCCAL, SUBLINGUAL
- Active Ingredients
- BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE DIHYDRATE
Indications and Usage
1 INDICATIONS AND USAGE Buprenorphine and naloxone sublingual tablets are indicated for maintenance treatment of opioid dependence. Buprenorphine and naloxone sublingual tablets should be used as part of a complete treatment plan that includes counseling and psychosocial support. Buprenorphine and naloxone sublingual tablets contain buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist, and is indicated for the maintenance treatment of opioid dependence. ( 1 ) Buprenorphine and naloxone sublingual tablets should be used as part of a complete treatment plan that includes counseling and psychosocial support. ( 1 )